BioSpace News Archive

Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today that it will present its full-year financial results for 2020 on April 6.

Monopar Therapeutics Inc. announced the publication of a peer-reviewed study titled “Engineered Antibody Fragment against the Urokinase Plasminogen Activator for Fast Delineation of Triple-Negative Breast Cancer by Positron Emission Tomography.” Urokinase plasminogen activator is an established biomarker in current breast cancer clinical practice guidelines and its presence is used to select appropriate drug treatment.

Tiziana Life Sciences. (NASDAQ: TLSA; LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, is pleased to confirm that, in order to finalise the distribution of shares in Accustem Sciences Limited (" Accustem ") to the holders of Tiziana shares in the US via its ADS program, it has recently filed a Form 20-F with the Securities Exchange Commission in the USA (the " SEC

Exebacase Phase 3 DISRUPT study enrollment ongoing in patients with Staph aureus bloodstream infections; results from interim futility analysis anticipated in H2 2021

BridGene Biosciences, Inc. , a biotechnology company using cutting-edge technology to discover and develop small molecules for hard-to-drug therapeutic targets, announced today a strategic research collaboration with Takeda Pharmaceutical

Horizon Therapeutics plc to Resupply Market With TEPEZZA ® (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) Beginning in April

Merck Announces Acquisition of Alydia Health on behalf of its Planned Spinoff of Organon Acquisition underscores Organon’s commitment to improving the health of women by addressing unmet medical need in maternal health through safer childbirth

IONIQ Sciences, Inc. is developing a rapid and non-invasive multi-cancer screen for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. Today IONIQ Sciences announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensi

MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in utilizing birth tissue as a platform for regenerative medicine, today announced that the Company has been awarded a Group Purchasing Agreement for its amniotic tissue portfolio with Premier Inc.’s Synergizing for Unparalleled Results in Procurement and Strategic Sourcing (SURPASS) purchasing program.

Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that enrollment is complete in the pivotal GEM-3 study of B-VEC for dystrophic epidermolysis bullosa (DEB).